Sue Watson
About Sue Watson
Sue Watson serves as the Senior Director of Medical Science Liaisons at Nektar Therapeutics, where she leads a national oncology team. With over twenty years of experience in pharmaceutical medical affairs, she has held various leadership roles at The Janssen Pharmaceutical Companies of Johnson & Johnson and has a strong background in health economics and outcomes research.
Current Role at Nektar Therapeutics
Sue Watson serves as the Senior Director of Medical Science Liaisons at Nektar Therapeutics, a position she has held since 2020. In this role, she leads a national oncology medical science liaison team, focusing on providing scientific, research, and educational support across various tumor types. Her leadership contributes to the alignment of resources and maximization of impact within the organization.
Previous Experience at Janssen Pharmaceutical
Watson has extensive experience at The Janssen Pharmaceutical Companies of Johnson & Johnson, where she held multiple roles over a span of 16 years. She served as Senior Director of Health Economics & Outcomes Research from 2010 to 2017, Scientific Director for the Oncology - Hematology MSL Team from 2017 to 2020, and National Field Director for Health Economics & Outcomes Research from 2004 to 2010. Her tenure included positions such as Associate Director of Outcomes Research and Regional Manager for Health System Strategies.
Pharmaceutical Career Background
With over twenty years of experience in pharmaceutical medical affairs, Watson has worked in diverse scientific and health economics arenas. Her career began as an Ambulatory Care Pharmacist at Kaiser Permanente from 1991 to 1993. She also held roles at Cardinal Health, including Area Clinical Manager and Manager of Clinical Affairs Hospital Pharmacy, contributing to her comprehensive understanding of the pharmaceutical landscape.
Education and Expertise
Watson's educational background includes a PharmD from the University of California, San Francisco, and a Clinical Pharmacy Residency from Duke University School of Medicine. She also studied Biology at Boston University. Her expertise encompasses national strategic planning, CMS and payor relations, and field associate mentoring and coaching, which she applies to her leadership roles.
Skills and Acknowledgments
Watson is recognized for her strong presentation, communication, and organizational skills. She has directed complex projects across multiple therapeutic areas, demonstrating her ability to manage change and align resources effectively within organizations. Her experience allows her to navigate the intricacies of the pharmaceutical industry successfully.